As International Men's Day is celebrated this week, prostate cancer survivors are emphasizing the critical importance of ...

The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use ...

A groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells. Prostate cancer ranks as the second most common cancer among men globally. Despite recent ...

Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the United ...

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to ...

Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of ...

1Department of Neuroscience, UT Southwestern Medical Center, Dallas, Texas. 4Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas ...

Ryland Fisher shares his personal journey of overcoming prostate cancer, reflecting on the challenges and lessons learned one year after his life-changing surgery. On Friday, 1 November, it will be ...

Active surveillance is increasingly chosen for favorable intermediate-risk prostate cancer, considering factors like PSA and cancer location. Treatment decisions should involve comprehensive ...

If you have any of these signs, you should see your doctor as soon as possible. Learn more about prostate cancer from the National Cancer Institute. Huntsman Cancer Institute’s Urologic Cancers ...

The new therapy combines two existing cancer drugs, enzalutamide and talazoparib. Enzalutamide, known by its brand name XTANDI, has been used as a treatment for metastatic castration-resistant ...

Prostate cancer can appear after the age of 50 and over, with the highest number of cases among Jews at the age of 70 to 74 and among Arabs at the age of 75 and over. Micrograph of prostate cancer ...